In our study, we identified four immune inhibitory checkpoint molecules (PD-1, HVEM, LAG-3, and TIM-3) and two immune co-stimulatory checkpoint molecules (CD27 and CD40) to be significantly elevated in CVL collected from patients with cervical cancer compared with healthy women or women with precancerous dysplasia. This evidence concerns the gene LAG3 and cervical cancer.